Table 2 Prevalence of high-risk human papillomavirus (HPV) in women with sufficient DNA for analyses in women living with HIV compared to women matched (1:5) on prior screening history and age from the general Danish population
Women living with HIV 295 | Women from the general population 1,475 | p-value | |
|---|---|---|---|
High-risk HPV positive, n(%) | |||
Yes | 78 (26.4) | 245 (16.6) | <0.0001 |
No | 217 (73.6) | 1,230 (83.4) | |
Number of genotypes, mean (range) | 1.54 (1–4) | 1.38 (1–5) | 0.047 |
Number of infections, n(%) | |||
Single | 48 (61.5) | 182 (74.3) | 0.030 |
Multiple (>1) | 30 (38.5) | 63 (25.7) | |
All high-risk genotypes present targeted by the 4-valent HPV vaccinea, n(% of the HPV positive patients) | |||
Yes | 8 (10.3) | 52 (21.2) | 0.030 |
No | 70 (89.7) | 193 (78.8) | |
All high-risk genotypes present targeted by the 9-valent vaccineb, n(% of the HPV positive patients) | |||
Yes | 42 (53.9) | 155 (63.3) | 0.14 |
No | 36 (46.1) | 90 (36.7) | |
Presence of ≥1 high-risk genotypes targeted by the 4-valent vaccinea, n(% of the HPV positive patients) | |||
Yes | 21 (26.9) | 76 (31.0) | 0.49 |
No | 57 (73.1) | 169 (69.0) | |
Presence of ≥1 high-risk genotypes targeted by the 9-valent vaccineb, n(% of the HPV positive patients) | |||
Yes | 61 (78.2) | 194 (79.2) | 0.85 |
No | 17 (21.8) | 51 (20.8) | |